Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDUS
2451
DELISTED
Radius Recycling
RDUS
| $1.22M | ﹤0.01% |
68,996
-69,100
| -50% | -$1.07M |
|
2452
MediciNova
MNOV
$64.5M
| $1.21M | ﹤0.01% |
223,683
-21,217
| -9% | -$112K |
|
|
EVOP
2453
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $1.21M | ﹤0.01% |
52,900
-85,200
| -62% | -$1.69M |
|
|
PAE
2454
DELISTED
PAE Incorporated Class A Common Stock
PAE
| $1.21M | ﹤0.01% |
+126,200
| New | +$1.12M |
|
2455
Farmers & Merchants Bancorp
FMAO
$489M
| $1.2M | ﹤0.01% |
56,400
-7,600
| -12% | -$168K |
|
|
GMLP
2456
DELISTED
Golar LNG Partners LP
GMLP
| $1.19M | ﹤0.01% |
461,704
-38,676
| -8% | -$98K |
|
|
SEAC
2457
DELISTED
Seachange International Inc
SEAC
| $1.19M | ﹤0.01% |
39,337
-21,795
| -36% | -$1.02M |
|
2458
Origin Bancorp
OBK
$1.68B
| $1.19M | ﹤0.01% |
53,900
+18,200
| +51% | +$373K |
|
|
OTRK
2459
DELISTED
Ontrak
OTRK
| $1.19M | ﹤0.01% |
+532
| New | +$1.07M |
|
2460
Park National Corp
PRK
$3.75B
| $1.18M | ﹤0.01% |
16,805
-32,695
| -66% | -$2.39M |
|
2461
OneWater Marine
ONEW
$199M
| $1.18M | ﹤0.01% |
+48,700
| New | +$688K |
|
|
ARCH
2462
DELISTED
Arch Resources, Inc.
ARCH
| $1.18M | ﹤0.01% |
41,600
-12,900
| -24% | -$401K |
|
|
BCYC
2463
Bicycle Therapeutics
BCYC
$274M
| $1.18M | ﹤0.01% |
74,700
+55,900
| +297% | +$859K |
|
|
SBT
2464
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $1.17M | ﹤0.01% |
327,877
+27,944
| +9% | +$92K |
|
2465
Coastal Financial
CCB
$786M
| $1.17M | ﹤0.01% |
80,577
-18,463
| -19% | -$243K |
|
2466
Colony Bankcorp
CBAN
$471M
| $1.17M | ﹤0.01% |
99,278
+2,400
| +2% | +$27.9K |
|
2467
NETGEAR
NTGR
$653M
| $1.17M | ﹤0.01% |
+45,100
| New | +$1.1M |
|
|
VRTV
2468
DELISTED
VERITIV CORPORATION
VRTV
| $1.17M | ﹤0.01% |
68,800
-71,300
| -51% | -$840K |
|
2469
BrightView Holdings
BV
$1.09B
| $1.16M | ﹤0.01% |
+103,900
| New | +$1.26M |
|
|
AUTL
2470
Autolus Therapeutics
AUTL
$567M
| $1.16M | ﹤0.01% |
72,400
-88,096
| -55% | -$977K |
|
2471
Sutro Biopharma
STRO
$343M
| $1.16M | ﹤0.01% |
+14,951
| New | +$1.43M |
|
2472
Global Net Lease
GNL
$1.86B
| $1.16M | ﹤0.01% |
69,300
-534,821
| -89% | -$7.65M |
|
|
FPAY
2473
DELISTED
FlexShopper
FPAY
| $1.15M | ﹤0.01% |
662,872
-55,559
| -8% | -$75.9K |
|
2474
The Joint Corp
JYNT
$120M
| $1.15M | ﹤0.01% |
75,178
+12,100
| +19% | +$158K |
|
2475
First US Bancshares
FUSB
$90.8M
| $1.14M | ﹤0.01% |
163,499
+458
| +0.3% | +$3.22K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.